My name is Frances. I’m 24 years old and I recently started my PhD at Queen’s University Belfast.
After taking biology classes at university, I found I enjoyed working in a lab and loved the idea of helping people through medical research.
2016 was an amazing year for MS research and progress is not slowing down. We look back at some of the key moments and take a sneak peek at what we can expect in 2017.
Research wins in 2016
A big moment for progressive MS
In September we announced the International Progressive MS Alliance would invest over £10 million in progressive MS research.
Low vitamin D levels in newborns could increase their future risk of MS, according to new research.
Scientists found that children born with very low levels of vitamin D were more likely to develop MS in later life.
One of our strategic goals is to give people with MS more certainty about their future. To help achieve this, researchers are investigating the biomarkers of MS.
What’s a biomarker?
Biological markers (or biomarkers) are detectable changes in the body. They can be anything from molecules in your blood to visible physical changes.
Running has made the news recently with an animal study that looks at the impact it has on the brain. What did it show? We take a look behind the headlines.
Not always getting the care that I’ve needed has been pretty hard at times, so I was really interested in the results of the My MS, My Needs survey.
The survey aimed to find out more about access to treatment, care and support among people with MS.
It’s never been easier to access information about health issues. With science journals becoming more freely available and medical research receiving more media attention than ever, how can we know which research to trust?